Conclusions patients taking warfarin displayed significant higher level of anxiety than patients discontinued warfarin. This may due to the side effects of taking warfarin.

The paper says that stent thrombosis is the "leading adverse event" associated with early antiplatelet discontinuation in patients with DES and carries a mortality rate of 20-45%.

Conclusion: the therapeutic method used in treating group is a good one for treating post traumatic thrombosis in deep vein of lower limb.